These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells. Chang AL; Miska J; Wainwright DA; Dey M; Rivetta CV; Yu D; Kanojia D; Pituch KC; Qiao J; Pytel P; Han Y; Wu M; Zhang L; Horbinski CM; Ahmed AU; Lesniak MS Cancer Res; 2016 Oct; 76(19):5671-5682. PubMed ID: 27530322 [TBL] [Abstract][Full Text] [Related]
7. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension. Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278 [TBL] [Abstract][Full Text] [Related]
8. The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia. Popiolek-Barczyk K; Ciechanowska A; Ciapała K; Pawlik K; Oggioni M; Mercurio D; De Simoni MG; Mika J Mol Cell Probes; 2020 Dec; 54():101671. PubMed ID: 33160071 [TBL] [Abstract][Full Text] [Related]
9. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes. Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442 [TBL] [Abstract][Full Text] [Related]
18. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds? Fei L; Ren X; Yu H; Zhan Y Front Immunol; 2021; 12():771210. PubMed ID: 34804061 [TBL] [Abstract][Full Text] [Related]
19. The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons. Edman LC; Mira H; Arenas E Exp Cell Res; 2008 Jun; 314(10):2123-30. PubMed ID: 18420193 [TBL] [Abstract][Full Text] [Related]
20. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]